ACTRN12615001111561招募中3 期
Chronic hepatitis C virus genotype 4 infected patients treated with a either one of generic Sofosbuvir plus ribavirin for 3 months versus 6 months duration based on their very rapid or ultra rapid virologic response
Mostafa Yakoot0 个研究点目标入组 200 人开始时间: 2015年10月21日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Chronic Hepatitis C genotype 4 infection with HCV RNA levels > 4 Log 10
排除标准
- •Other causes of chronic hepatitis such as hepatitis B or autoimmune hepatitis.
- •critically ill patients and severe organ dysfunctions
研究者
相似试验
进行中（未招募）
1 期
Four weeks treatment for chronic hepatitis C in patients under 50 years of age with no significant liver fibrosisEUCTR2017-005179-21-DKDepartment of infectious Diseases, Odense University Hospital227
已完成
不适用
Spirulina Platensis in the Treatment of Chronic Hepatitis C Virus (HCV) InfectioACTRN12610000958088Abbass Helmy Charity60
已完成
4 期
CHESS - Curing Hepatitis C: Effect on the Endothelium and cardiovaScular riSk - a pilot single arm trial, assessing the effect of hepatitis C virus (HCV) treatment with 12 weeks of paritaprevir/ritonavir/ombitasvir, dasabuvir +/- ribavirin on endothelial function.Hepatitis C virus infectionEndothelial functionInfection - Other infectious diseasesCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12615001167550John Hunter Hospital16
已完成
2 期
A pilot phase II open-label study of oglufanide disodium in patients with chronic hepatitis CChronic hepatitis CInfection - Other infectious diseasesACTRN12607000418471Implicit Bioscience Pty Ltd17
招募中
不适用
Hepatitis C virus-related liver disease cohort study in KoreaCertain infectious and parasitic diseasesKCT0000306Korea Centers for Disease Control and Prevention100